ACO Name and Location
HHC ACO Inc.
50 Water Street, 3rd Floor
New York, NY 10004
ACO Primary Contact
Matthew Siegler
212-788-3479
SieglerM@nychhc.org
Organizational Information
ACO participants:
| ACO Participants | ACO Participant in Joint Venture |
| Community Healthcare Network, Inc. | Y |
| Icahn School of Medicine at Mount Sinai (DBA: Mount Sinai Elmhurst Faculty Practice Group) | Y |
| New York City Health and Hospitals Corporation | Y |
| Physician Affiliate Group of New York, P.C. | Y |
| Union Community Health Center, Inc. | Y |
| Urban Health Plan, Inc. | Y |
ACO governing body:
| Member | ||||||
| First Name | Last name | Title/Position | Member’s Voting Power – Expressed as a percentage or number | Membership Type | ACO Participant Legal Business Name, if Applicable | ACO Participant DBA, if Applicable |
| Mitchell | Katz | Chair | 9.09% | ACO Participant Representative | New York City Health and Hospitals Corporation | |
| Matthew | Siegler | CEO | 9.09% | ACO Participant Representative | New York City Health and Hospitals Corporation | |
| Gary | Kalkut | Vice President | 9.09% | ACO Participant Representative | New York City Health and Hospitals Corporation | |
| John E. | Ulberg, Jr. | Treasurer | 9.09% | ACO Participant Representative | New York City Health and Hospitals Corporation | |
| Andrea | Cohen | Secretary | 9.09% | ACO Participant Representative | New York City Health and Hospitals Corporation | |
| Nicole | Jordan-Martin | Voting Member | 9.09% | ACO Participant Representative | New York City Health and Hospitals Corporation | |
| Daniel | Napolitano | Voting Member | 9.09% | ACO Participant Representative | Community Healthcare Network, Inc. | |
| Edward | Chew | Voting Member | 9.09% | ACO Participant Representative | Physician Affiliate Group of New York, P.C. | |
| Joan | Curcio | Voting Member | 9.09% | ACO Participant Representative | Icahn School of Medicine at Mount Sinai | Mount Sinai Elmhurst Faculty Practice Group |
| Hyacinth | Peart | Voting Member | 9.09% | Medicare Beneficiary Representative | ||
| Warren | Seigel | Voting Member | 9.09% | ACO Participant Representative | Physician Affiliate Group of New York, P.C. |
Key ACO clinical and administrative leadership:
ACO Executive: Matthew Siegler
Medical Director: Anthony Okolo, MD
Compliance Officer: Catherine Patsos, Esq.
Quality Assurance/Improvement Officer: Michael Levitin
Associated committees and committee leadership:
| Committee Name | Committee Leader Name and Position |
| Governance Committee | Mitchell Katz, MD, Board Chair |
| Clinical Leadership & Quality Assurance Committee | Anthony Okolo, MD, Medical Director |
| Audit Committee | John Ulberg, MPH, Treasurer |
Types of ACO participants, or combinations of participants, that formed the ACO:
- ACO professionals in a group practice arrangement
- Hospital employing ACO professionals
- Partnerships or joint venture arrangements between hospitals and ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- Third Agreement Period
- Performance Year 2024, $7,210,142
- Performance Year 2023, $6,111,407
- Performance Year 2022, $8,017,376
- Performance Year 2021, $4,007,011
- Performance Year 2020, $11,415,299
- Performance Year 2019, $4,621,337
- Second Agreement Period
- Performance Year 2019, $4,621,337
- Performance Year 2018, $2,967,275
- Performance Year 2017, $2,182,360
- Performance Year 2016, $1,586,859
- First Agreement Period
- Performance Year 2015, $6,052,364
- Performance Year 2014, $2,644,605
- Performance Year 2013, $3,639,766
Shared Savings Distribution
- Third Agreement Period
- Performance Year 2024
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 42%
- Proportion of distribution to ACO participants: 58%
- Performance Year 2023
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 42%
- Proportion of distribution to ACO participants: 58%
- Performance Year 2022
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 42%
- Proportion of distribution to ACO participants: 58%
- Performance Year 2021
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 42%
- Proportion of distribution to ACO participants: 58%
- Performance Year 2020
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 42%
- Proportion of distribution to ACO participants: 58%
- Performance Year 2019
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 42%
- Proportion of distribution to ACO participants: 58%
- Performance Year 2024
- Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 42%
- Proportion of distribution to ACO participants: 58%
- Performance Year 2018
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 48%
- Proportion of distribution to ACO participants: 52%
- Performance Year 2017
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 57%
- Proportion of distribution to ACO participants: 43%
- Performance Year 2016
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 85%
- Proportion of distribution to ACO participants: 15%
- Performance Year 2019
- First Agreement Period
- Performance Year 2015
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 20%
- Proportion of distribution to ACO participants: 80%
- Performance Year 2014
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 28%
- Proportion of distribution to ACO participants: 72%
- Performance Year 2013
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 36%
- Proportion of distribution to ACO participants: 64%
- Performance Year 2015
Quality Performance Results
2024 Quality Performance Results:
Quality performance results are based on the CMS Web Interface collection type.
| Measure # | Measure Title | Collection Type | Performance Rate* | ACO Mean |
| 318 | Falls: Screening for Future Fall Risk | CMS Web Interface | 79.6 | 89.42 |
| 110 | Preventive Care and Screening: Influenza Immunization | CMS Web Interface | 67.11 | 70.76 |
| 226 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | CMS Web Interface | 81.82 | 79.29 |
| 134 | Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan | CMS Web Interface | 85.77 | 80.97 |
| 113 | Colorectal Cancer Screening | CMS Web Interface | 75.08 | 77.14 |
| 112 | Breast Cancer Screening | CMS Web Interface | 80.00 | 80.36 |
| 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS Web Interface | 94.34 | 87.05 |
| 370 | Depression remission at Twelve Months | CMS Web Interface | 12.20 | 16.58 |
| 001 | Diabetes Mellitus: Hemoglobin A1c Poor Control (< 9%) | CMS Web Interface | 11.64 | 9.84 |
| 236 | Controlling High Blood Pressure | CMS Web Interface | 79.84 | 77.80 |
| 321 | CAHPS for MIPS | CAHPS for MIPS Survey | 3.60 | 6.25 |
| 479 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups | Administrative Claims | 0.163 | 0.155 |
| 484 | All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs | Administrative Claims | — | — |
| CAHPS-1 | Getting Timely Care, Appointments, and Information | CAHPS for MIPS Survey | 82.30 | 83.70 |
| CAHPS-2 | How Well Providers Communicate | CAHPS for MIPS Survey | 91.07 | 93.96 |
| CAHPS-3 | Patient’s Rating of Provider | CAHPS for MIPS Survey | 86.72 | 92.43 |
| CAHPS-4 | Access to Specialists | CAHPS for MIPS Survey | 75.98 | 75.76 |
| CAHPS-5 | Health Promotion and Education | CAHPS for MIPS Survey | 64.52 | 65.48 |
| CAHPS-6 | Shared Decision Making | CAHPS for MIPS Survey | 53.91 | 62.31 |
| CAHPS-7 | Health Status and Functional Status | CAHPS for MIPS Survey | 73.20 | 74.14 |
| CAHPS-8 | Care Coordination | CAHPS for MIPS Survey | 80.84 | 85.89 |
| CAHPS-9 | Courteous and Helpful Office Staff | CAHPS for MIPS Survey | 88.32 | 92.89 |
| CAHPS-11 | Stewardship of Patient Resources | CAHPS for MIPS Survey | 26.31 | 26.98 |
*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.
*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs’ providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
Payment Rule Waivers
- Waiver for Payment for Telehealth Services:
- Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR §425.612(f) and 42 CFR §425.613.